Neimeth International Pharmaceuticals Plc has concluded arrangements to commence its N3.67 billion right issue to the existing shareholders of the company in August. The pharmaceutical company held a Completion Board Meeting to float a Rights Issue of N3.67 billion through…
International Pharmaceuticals PLC have approved the plan of the Board to raise the sum of N5 billion through a hybrid offer of Rights to existing shareholders and private placement. The money will be used to finance major long term expansion…
By Kayode Tokede The Board of Directors of Neimeth Pharmaceuticals has revealed plans to raise N5billion in additional equity upon approval by shareholders of the company. The Company Secretary, Neimeth Pharmaceuticals, Mrs. Florence Onhenekwe said in a statement to The…
By Kayode Tokede with news agency Neimeth International Pharmaceutical Plc has emerged the best performing stock in 2020 in percentage terms, appreciating by 259.68 per cent, the News Agency of Nigeria (NAN) reports. Statistics obtained from the Nigerian Stock Exchange…
By Kayode Tokede The Board of Directors of Neimeth International Pharmaceuticals Plc, has proposed a total final dividend of N123.45 million to be distributed to the shareholders of the company, as final dividend for the period ended September 30,2020. This…
